A detailed history of Asempa Wealth Advisors transactions in Precigen, Inc. stock. As of the latest transaction made, Asempa Wealth Advisors holds 11,601 shares of PGEN stock, worth $53,480. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,601
Holding current value
$53,480
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$3.12 - $4.61 $36,195 - $53,480
11,601 New
11,601 $48.5 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $960M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Asempa Wealth Advisors Portfolio

Follow Asempa Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asempa Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Asempa Wealth Advisors with notifications on news.